Clinical Trial Update: Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Lidoderm (lidocaine patch 5%) for moderate-to-severe pain in carpal tunnel syndrome has been terminated; the update discusses safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carpal Tunnel Syndrome

Drugs mentioned

• Lidoderm (lidocaine patch 5%)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Carpal Tunnel Syndrome | Phase 3 | Status: TERMINATED